The metabolic syndrome is characterized by a constellation of metabolic risk factors including, but not limited to insulin resistance, abdominal obesity, elevated blood pressure, a poor cholesterol profile, and increased inflammatory markers. Many of the factors that characterize the metabolic syndrome have also been associated with breast cancer risk; however, the impact of the metabolic syndrome on breast cancer appears to be poorly understood.
Newly published breast cancer research has examined the potential impact of the metabolic syndrome on breast cancer in postmenopausal women. For this new study , the investigators recruited 105 postmenopausal women with newly diagnosed breast cancer and took a detailed clinical history that included a metabolic screening and body composition analysis. 51% of postmenopausal women with a more advanced breast cancer (Stage 2-4) were diagnosed with the metabolic syndrome compared to only 12% of women with early stage breast cancer. Patients whose breast cancer had spread to include their lymph nodes were also more likely to have the metabolic syndrome.
This study adds to the growing amount of evidence pointing to the dangers of obesity, especially abdominal obesity, in regards to breast cancer risk. The results of this research showed that the metabolic syndrome and obesity were common in postmenopausal breast cancer patients and appeared to be linked to more advanced breast cancer. Leading a healthy lifestyle through proper nutrition and physical activity is a critical part of maintaining a healthy body weight and long-term health. Additionally, many foods have been reported to help reduce breast cancer risk, so including such foods as part of a healthy, balanced diet is a good way to support a healthy lifestyle.
You can read my book Fight Now: Eat & Live Proactively Against Breast Cancer ( www.fightBCnow.com ) to learn more about the importance of diet and nutrition in the fight against breast cancer.